The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

My colleague Brittany Trang calculates that Vinay Prasad lasted fewer than eight Scaramuccis at the FDA — a Scaramucci is a ...

VC firm Frazier Life Sciences has raised a $1.3 billion fund, the firm’s largest to date and one of the few new biotech ...

Facing a range of competitive and government challenges, Moderna announced layoffs Thursday affecting 10% of its workforce.

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.

Moderna announced layoffs affecting 10% of its workforce amid government and competitive challenges to its vaccine business ...

Prasad’s departure may outline the political limits of medical skepticism in the Republican party, at least when it comes to ...

Alnylam Pharmaceuticals’ new cardiovascular drug is off to a stronger-than-expected launch. The treatment, Amvuttra, brought ...

Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications ...

The immediate ebullient reaction to Vinay Prasad’s ouster is understandable, and may ultimately be the correct one, Adam ...

In many ways, despite what RFK Jr. and Rep. Paul Gosar claim, the Vaccine Injury Compensation Program is more friendly to ...